drugset / Trial / NCT01634178

Effect of Food on the Pharmacokinetics of Apremilast (CC-10004) in Healthy Adults

NCT01634178

Phase 1 Completed 46 enrolled Amgen
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of the study is to evaluate the effects of a high fat meal on the pharmacokinetics of a single dose of 30 mg apremilast in healthy adults.

Timeline

Start
2012-02-01
Primary completion
2012-03-01
Completion
2012-03-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Apremilast Small molecule 30 mg Oral

Indications

No indication recorded.